Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,489
datasets available to search
ShareScore release 0.9.0
Dataset results
2,489 results for “Sars-CoV-2”
A Safety and Immunogenicity Study of Inactivated SARS-CoV-2 Vaccine (Vero Cells) in Healthy Population Aged 18 Years and Above(COVID-19)
ClinicalTrials.gov study NCT04758273. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Host-pathogen Interactions During SARS-CoV-2 Infection
ClinicalTrials.gov study NCT04376476. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study to Evaluate the Safety & Immunogenicity of IMNN-101 Administered in Healthy Adults Previously Vaccinated Against SARS-CoV-2
ClinicalTrials.gov study NCT06283459. IPD Sharing: Not stated. Countries: 1. Publications: 0.
SARS-CoV-2, TESTOSTERONE AND MALE FRAGILITY
ClinicalTrials.gov study NCT06177002. IPD Sharing: NO. Countries: 1. Publications: 0.
Evaluation of Safety, Tolerability, Reactogenicity, Immunogenicity of Baiya SARS-CoV-2 Vax 2 as a Booster for COVID-19
ClinicalTrials.gov study NCT05873374. IPD Sharing: NO. Countries: 1. Publications: 0.
Longitudinal At Home Smell Testing to Detect Infection by SARS-CoV-2
ClinicalTrials.gov study NCT05040659. IPD Sharing: YES. Countries: 1. Publications: 0.
Residual SARS-CoV-2 Presence in the Respiratory Tract and Lung Parenchyma (After SARS-CoV-2 Infection or COVID-19)
ClinicalTrials.gov study NCT04775134. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Research & Evaluation of LumiraDx SARS-CoV-2 (COVID-19) Point of Care Ab Test
ClinicalTrials.gov study NCT04597047. IPD Sharing: NO. Countries: 1. Publications: 0.
A Phase IV Vaccine Study Under the National Cohort Study of Effectiveness and Safety of SARS-CoV-2 (COVID-19) Vaccines.
ClinicalTrials.gov study NCT06360744. IPD Sharing: NO. Countries: 1. Publications: 0.
Coagulopathy and Vasculopathy Assessment as a Predictor of the Severity of SARS-CoV-2 / COVID-19 Infection
ClinicalTrials.gov study NCT04624997. IPD Sharing: YES. Countries: 1. Publications: 0.
Post-Marketing Safety Study in Japan in Participants With High Risk of Severe Exacerbation of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) mRNA-1273 COVID-19 Vaccine
ClinicalTrials.gov study NCT05894525. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Immunogenicity and Safety of an Inactivated SARS-CoV-2 Vaccine Coadministered With Two Attenuated Vaccines
ClinicalTrials.gov study NCT05952505. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Skeletal Muscle Wasting in SARS-CoV-2
ClinicalTrials.gov study NCT04698798. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Safety, Reactogenicity, and Immunogenicity Trial of CV2CoV mRNA Vaccine Against SARS-CoV-2 in Seropositive Adult Participants
ClinicalTrials.gov study NCT05260437. IPD Sharing: YES. Countries: 1. Publications: 0.
Analysis of Cardiac Damage Post Infection With SARS-CoV-2 and Post Vaccination Against COVID-19
ClinicalTrials.gov study NCT05124223. IPD Sharing: NO. Countries: 1. Publications: 0.
Evaluation of the Efficacy of Xylitol Nasal Spray Against SARS-CoV-2
ClinicalTrials.gov study NCT04610801. IPD Sharing: NO. Countries: 1. Publications: 0.
Antibody Seroprevalence and Rate of Asymptomatic Infections With SARS-CoV-2 in Austrian Hospital Personnel.
ClinicalTrials.gov study NCT04354779. IPD Sharing: NO. Countries: 1. Publications: 0.
CU-COMMITS: COVID-19 Care in Black and Latino Communities and Households. Clinical and Molecular Outcomes of SARS-CoV-2
ClinicalTrials.gov study NCT05467930. IPD Sharing: NO. Countries: 1. Publications: 0.
Evaluation of Alisporivir for the Treatment of Hospitalised Patients With Infections Due to SARS-CoV-2 (COVID-19)
ClinicalTrials.gov study NCT04608214. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Immunogenicity Against SARS-CoV-2 in COVID-19 Close Contacts
ClinicalTrials.gov study NCT05094635. IPD Sharing: NO. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.